empty

Clinical

Swallowable sponge could reduce need for endoscopies

In trials just one in 30 of the patients offered the Cytosponge were referred for an endoscopy.

Viewpoint: To D or not to D in Covid?

Vitamin D deficiency is associated with increased severity of Covid-19 and greater risks of hospitalisation and death — so should supplementation become routine?

Ivermectin for Covid-19: a cheap drug with a remarkable effect

Numerous clinical trials with ivermectin in Covid-19 have shown consistent, large improvements inclinical outcomes. It must be authorised for use in the UK.

Vaccines 'highly effective' in reducing severe Covid-19 in older adults

First dose protection ranged between 57-61 per cent for Pfizer vaccine and between 60-73 per cent for the Oxford-AZ vaccine (ChAdOx1)

Vaccine roll-out should not be politicised

The JCVI's decisions should not be used as a political football, says Dr Anthony Cox of Birmingham University School of Pharmacy 

Fatigue, insomnia and anxiety are long term consequences of Covid-19

Study in The Lancet looks at Covid patients six months after discharge.

Understanding clinical test results

How can the results of clinical tests and their implications be clearly explained to patients? We offer some pointers.

Analysis: Improving access to contraception

Calls to reclassify oral contraceptives in order to increase accessibility and reduce unintended pregnancies are getting louder.

How has Covid affected mental health prescribing?

The Covid-19 pandemic seems to have changed psychopharmaceutical prescribing patterns in England, at least in the short-term.

Erythromycin alert for patients with prolonged QT interval

Potential drug interaction between rivaroxaban and erythromycin resulting in increased risk of bleeding identified

Covid-19: Playing the long game

Observational studies and clinical trials need to determine how long the changes in people with Covid persist and come up with ways to treat and prevent long-Covid, writes Mark Greener

Why all the fuss about biosimilars?

Biosimilars have been exciting attention in secondary care for over a decade but seem to have made little impact in the community. 

Over-50s suffering with loneliness at risk of diabetes

KCL study shows a strong relationship between loneliness and the later onset of type 2 diabetes

Discovery of four Covid-19 risk groups could help guide treatment

A risk identification tool uses the groupings to help clinical staff choose the best course of treatment for patients.

Value of statins in the elderly confirmed

Starting statins reduces the risk of all-cause and cardiovascular mortality among people aged 75 years and older, a new study finds. 

Study to look at long term impacts of Covid-19

The study's findings will support the development of strategies for clinical and rehabilitation care

Most vulnerable children no longer need to shield

Independent evidence from RCPCH shows the risk of serious illness for children and young people is low.

Hydroxychloroquine 'ineffective in treating Covid-19'

Preliminary results from RECOVERY trial show hydroxychloroquine has no effect on mortality.

Hospitalised Covid patients with diabetes at risk

Study looking at impact of Covid-19 on hospitalised patients with diabetes finds one in ten die within seven days of admission

New PPI launched

Rosemont Pharmaceuticals has launched omeprazole powder for oral suspension.

Previous 1 2 3 4 5 ... 16 Next


This website is for healthcare professionals, people who work in pharmacy and pharmacy students. By clicking into any content, you confirm this describes you and that you agree to Pharmacy Magazine's Terms of Use and Privacy Policy.

We use essential, performance, functional and advertising cookies to give you a better web experience. Find out how to manage these cookies here. We also use Interest Based Advertising Cookies to display relevant advertisements on this and other websites based on your viewing behaviour. By clicking "Accept" you agree to the use of these Cookies and our Cookie Policy.